The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
SRC-1 and GRIP1 Coactivate Transcription with Hepatocyte Nuclear Factor 4
Open accessAbstract
Hepatocyte nuclear factor-4 (HNF4), a member of the nuclear receptor superfamily, plays an important role in tissue-specific gene expression, including genes involved in hepatic glucose metabolism. In this study, we show that SRC-1 and GRIP1, which act as coactivators for various nuclear receptors, associate with HNF4 in vivo and enhance its transactivation potential. The AF-2 domain of HNF4 is required for this interaction and for the potentiation of transcriptional activity by these coactivators. p300 can also serve as a coactivator with HNF4, and it synergizes with SRC-1 to further augment the activity of HNF4. HNF4 is also a key regulator of the expression of hepatocyte nuclear factor-1 (HNF1). The overexpression of SRC-1 or GRIP1 enhances expression from a HNF1 gene promoter-reporter in HepG2 hepatoma cells, and this requires an intact HNF4-binding site in the HNF1 gene promoter. Type 1 maturity onset diabetes of young (MODY), which is characterized by abnormal glucose-mediated insulin secretion, is caused by mutations of the HNF4 gene. A mutation of the HNF4-binding site in the HNF1 gene promoter has also been associated with MODY. Thus, HNF4 is involved in the regulation of glucose homeostasis at several levels and along with the SRC-1, GRIP1, and p300 may play an important role in the pathophysiology of non-insulin-dependent diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition to FOXA family members, HNF4A was previously shown to recruit several coactivators such as glucocorticoid receptor interacting protein 1, steroid receptor coactivator1 and cAMP response element binding proteins to regulate gene expression (41, 43).”
From Hepatocyte Nuclear Factor 4‐Alpha Is Essential for the Active Epigenetic State at Enhancers in Mouse Liver (2019) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,398
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
The CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,828
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R., Lathrop, M. G., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,610
Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80516-4 · Cited by 1,480
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
Torchia, J., Rose, D. W., Inostroza, J. A., Kamei, Y., Westin, S. K., Glass, C. K., & Rosenfeld, M. G. (1997) · Nature · doi:10.1038/42652 · Cited by 1,283
Steroid receptor coactivator-1 is a histone acetyltransferase
Spencer, T. E., Jenster, G. W., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Oñate, S. A., Tsai, S. Y., Tsai, M., et al. (1997) · Nature · doi:10.1038/38304 · Cited by 1,242
Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Flagged first, then by citations
Research works printed but not linked: 2
- Sladek, 1994, 11, 207
- Shibata, 1997, Recent Prog. Horm. Res., 52, 141
Cited by
Sorted by citations
Items 101–147 of 147
LXXLL Peptide Converts Transportan 10 to a Potent Inducer of Apoptosis in Breast Cancer Cells
Tints, K., Prink, M., Neuman, T., & Palm, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045680 · Cited by 23
The link between chromatin structure protein acetylation and cellular differentiation
Sartorelli, V. (2001) · Frontiers in bioscience · doi:10.2741/a665 · Cited by 23
Okamura, M., Shizu, R., Hosaka, T., Sasaki, T., & Yoshinari, K. (2019) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2019.04.005 · Cited by 22
Mechanism of Progesterone Receptor Action in the Brain
Mani, S., & O'Malley, B. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00045-0 · Cited by 21
Glucocorticoids and Immunity: Mechanisms of Regulation
Schoneveld, O., & Cidlowski, J. A. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50005-8 · Cited by 19
Hepatocyte nuclear factor (HNF)-4α-driven epigenetic silencing of the human PED gene
Ungaro, P., Teperino, R., Mirra, P., Longo, M., Ciccarelli, M., Raciti, G. A., Nigro, C., Miele, C., Formisano, P., & Bèguinot, F. (2010) · Diabetologia · doi:10.1007/s00125-010-1732-x · Cited by 19
Han, E. H., Rha, G. B., & Chi, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044007 · Cited by 18
Laine, B., Eeckhoute, J., Suaud, L., Briche, I., Furuta, H., Bell, G. I., & Formstecher, P. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01864-0 · Cited by 18
Eeckhoute, J., Briche, I., Kurowska, M., Formstecher, P., & Laine, B. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.07.096 · Cited by 16
Takezawa, T., Matsunaga, T., Aikawa, K., Nakamura, K., & Ohmori, S. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-126 · Cited by 15
Mechanism of Progesterone Receptor Action in the Brain
Mani, S. K., & O’Malley, B. W. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50056-1 · Cited by 15
Eeckhoute, J. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg850 · Cited by 15
Critical Role of Residues Defining the Ligand Binding Pocket in Hepatocyte Nuclear Factor-4α
Aggelidou, E., Ιορδανίδου, Π., Tsantili, P., Papadopoulos, G. E., & Hadzopoulou‐Cladaras, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401120200 · Cited by 14
La Estoria de España de Alfonso X: creación y evolución
Catalán, D. (1992) · Cited by 13
Hepatocyte nuclear factor 4α multiple isoforms, their functions, and their interactomes
Pulido, J. A. H., Boisvert, F., & Boudreau, F. (2023) · PROTEOMICS · doi:10.1002/pmic.202200372 · Cited by 12
Scribner, K. B., Odom, D. P., & McGrane, M. M. (2005) · Journal of Nutrition · doi:10.1093/jn/135.12.2774 · Cited by 12
Schilling, M. M., Oeser, J. K., Chandy, J. K., Flemming, B. P., Allen, S., & O’Brien, R. M. (2008) · Diabetologia · doi:10.1007/s00125-008-1050-8 · Cited by 11
Han, E. H., Singh, P., Lee, I., Urrutia, R. A., & Chi, Y. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009558 · Cited by 10
Wang, H., Ho, P., Lan, C., & Chang, M. D. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22008 · Cited by 9
Kinase/phosphatase regulation of CYP7A1
Diane, S. (2005) · Frontiers in bioscience · doi:10.2741/1652 · Cited by 9
Kim, M. J., Lee, W., Park, E., & Park, S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.049 · Cited by 8
Zhang, J., Yang, Y., Liu, H., & Hu, H. (2021) · Open Medicine · doi:10.1515/med-2021-0248 · Cited by 8
A scoring system for the follow up study of nuclear receptor coactivator complexes
Han, S. J., Jung, S. Y., Malovannaya, A., Kim, T., Lanz, R. B., Qin, J., & O’Malley, B. W. (2006) · Nuclear Receptor Signaling · doi:10.1621/nrs.04014 · Cited by 8
Peiler, G., Böckmann, B., Nakhei, H., & Ryffel, G. U. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8676-8683.2000 · Cited by 8
Therapeutic potential of Mediator complex subunits in metabolic diseases
Ranjan, A., & Ansari, S. A. (2017) · Biochimie · doi:10.1016/j.biochi.2017.10.012 · Cited by 7
In Pursuit of Genes of Glucose Metabolism
Granner, D. K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.x115.681353 · Cited by 7
Self-citationHarish, S. K. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.5.1047 · Cited by 7
Bi, Y., Wang, Y., & Xie, W. (2019) · Liver Research · doi:10.1016/j.livres.2019.09.004 · Cited by 7
Therapeutic Potential of HNF4α in End-stage Liver Disease
Díaz‐Aragon, R., Coard, M. C., Amirneni, S., Faccioli, L. A. P., Haep, N., Malizio, M. R., Motomura, T., Kocas‐Kilicarslan, Z. N., Ostrowska, A., Florentino, R. M., et al. (2021) · Organogenesis · doi:10.1080/15476278.2021.1994273 · Cited by 5
[Transcription factors in the adult beta cell].
Lazo-de-la-Vega-Monroy, M.-L., & Fernández‐Mejía, C. (2009) · PubMed · Cited by 4
Maturity-Onset Diabetes of the Young
Winter, W. E. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0507-5_4 · Cited by 4
Artemyev, V., Paremskaia, A. I., Dzhioeva, A. A., Mishina, D., Bogdanov, V. P., Krupinova, J. A., Mazloum, A., Feoktistova, S. G., Mityaeva, O. N., & Volchkov, P. (2025) · Cells · doi:10.3390/cells15010014 · Cited by 3
Development of Nuclear Receptor Homogeneous Assay Using the Lance™ Technology
Rouleau, N., Hurskainen, P., Bossé, R., & Hemmilä, I. A. (2006) · CRC Press eBooks · doi:10.1201/9781420015706-21 · Cited by 2
Divenko, M., & Mills, J. C. (2026) · Physiological Reviews · doi:10.1152/physrev.00033.2025 · Cited by 4
Progesterone Receptor Isoforms : functional Selectivity and Pharmacological Targeting
Khan, J. A. (2011) · theses.fr (ABES) · doi:10.70675/d565fcfezaed8z42f4za43az5b89ba52f3ae · Cited by 1
HNF4 as a Liver Gene Transcription Factor
Stafford, J. M., Wang, J.-C., Scott, D. K., Sugiyama, T., & Granner, D. K. (2000) · KARGER eBooks · doi:10.1159/000060927
Self-citationWirsing, A. (2010) · DuEPublico (University of Duisburg-Essen)
Nigro, C. (2011) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/8778
Schillinger, K. J., Tsai, S. Y., & Tsai, M. (2007) · Springer eBooks · doi:10.1007/978-0-387-40049-5_16
Thyroid Hormone Receptor Interacting Protein 3 (Trip3) Is a Novel Coactivator of Hepatocyte Nuclear
Yamagata, K., Yoshiuchi, I., Terasaki, J., Yang, Q., Fukui, K., Ihara, A., Zhu, Q., Asakura, T., Cao, Y., Imagawa, A., et al. (2002)
Glucocorticoid Receptor‐Mediated Signaling and Stress Metabolism
Uht, R. M., & Bhave, S. (2017) · Wiley eBooks · doi:10.1002/9783527697274.ch13
Sladek, F. M. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f91/2019.4
Laudet, V., & Gronemeyer, H. (2002) · Elsevier eBooks · doi:10.1016/b978-012437735-6/50025-4
Gárate‐Rascón, M. (2022) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · doi:10.15581/10171/65009
2A. Hepatocyte nuclear factor-4 receptors in GtoPdb v.2023.1
Sladek, F. M. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f91/2023.1
Metadata
- Authors
- Wang, J.-C., Stafford, J. M., & Granner, D. K.
- Affiliations
- Vanderbilt University Medical Center (US)
- Corresponding author
- Granner, Daryl K.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-11
- Volume
- 273
- Issue
- 47
- Pages
- 30847-30850
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC3968904
- OpenAlex
- W2082605633
- Cited by
- 147
- References
- 42
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 1 · 2019: 6 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 7 · 2014: 1 · 2013: 1 · 2012: 5
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Vanderbilt University
- National Institutes of Health (DK 20593)
- Vanderbilt Diabetes Research and Training Center, Vanderbilt University Medical Center
- National Institute of General Medical Sciences (GM 07347, T32GM007347)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK035107, DK 20593, DK 25107, R37DK035107, P30DK020593)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- HNF4, SRC-1, GRIP1, P300, transcriptional coactivator, nuclear receptor transactivation, AF-2 domain, HNF1, maturity-onset diabetes of the young, glucose homeostasis, hepatic gene expression, insulin secretion
- MeSH terms
- Binding Sites, Diabetes Mellitus, Type 2, DNA-Binding Proteins, Glucose, Homeostasis, Phosphoproteins, Promoter Regions, Genetic, Protein Binding, Recombinant Fusion Proteins, Transcription Factors, Transcriptional Activation, Saccharomyces cerevisiae Proteins, Histone Acetyltransferases, Hepatocyte Nuclear Factor 4, Nuclear Receptor Coactivator 2, Nuclear Receptor Coactivator 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review